Chuir Andóra in iúl don Choimisiún go nglacfaidh sé le cruthúnas ar vacsaíniú le haghaidh vacsaíní a bhfuil údarú uile-AE acu chomh maith le vacsaíní a bhfuil an nós imeachta maidir le liostú úsáide éigeandála de chuid EDS curtha i gcrích ina leith.
Andorra informed the Commission that it will accept proof of vaccination for vaccines with an EU-wide authorisation and vaccines that have completed the WHO Emergency Use Listing Procedure.
Féadfaidh an Eilvéis glacadh, chun na críche céanna, le deimhnithe vacsaínithe arna n-eisiúint ag na Ballstáit i gcomhréir le Rialachán (AE) 2021/953 i ndáil le vacsaín COVID-19 a thug údarás inniúil Ballstáit údarú margaíochta ina leith de bhun Threoir 2001/83/CE ó Pharlaimint na hEorpa agus ón gComhairle, i ndáil le vacsaín COVID-19 ar tugadh údarú sealadach maidir lena dháileadh de bhun Airteagal 5(2) den Treoir sin, nó i ndáil le vacsaín COVID-19 a bhfuil an nós imeachta maidir le liostáil úsáide éigeandála de chuid na Eagraíochta Domhanda Trádála curtha i gcrích ina leith.
Switzerland may also accept, for the same purpose, vaccination certificates issued by Member States in accordance with Regulation (EU) 2021/953 for a COVID-19 vaccine that has been granted a marketing authorisation by the competent authority of an Member State pursuant to Directive 2001/83/EC of the European Parliament and of the Council, a COVID-19 vaccine the distribution of which has been temporarily authorised pursuant to Article 5(2) of that Directive, or a COVID-19 vaccine that has completed the WHO emergency use listing procedure.
Chuir Stát Chathair na Vatacáine in iúl don Choimisiún go nglacfadh sé le cruthúnas ar vacsaíniú le haghaidh vacsaíní a bhfuil údarú uile-Aontais acu (i ndiaidh tuairim ón nGníomhaireacht Leigheasra Eorpach), vacsaíní ar dheonaigh údarás inniúil ó Bhallstát den Aontas údarú margaíochta dóibh, agus vacsaíní a bhfuil an próiseas liostaithe i ndáil le liosta úsáide éigeandála na hEagraíochta Domhanda Sláinte curtha i gcrích ina leith.
The Vatican City State informed the Commission that it will accept proof of vaccination for vaccines with an EU wide authorization (following an opinion by the European Medicines Agency), vaccines that have been granted a temporary marketing authorisation by the competent authority of an EU Member State, and vaccines that have completed the WHO Emergency Use listing procedure.
Chuir San Mairíne in iúl don Choimisiún go nglacfadh sé le cruthúnas ar vacsaíniú le haghaidh vacsaíní a bhfuil údarú uile-Aontais acu (i ndiaidh tuairim ón nGníomhaireacht Leigheasra Eorpach), vacsaíní ar dheonaigh údarás inniúil ó Bhallstát den Aontas údarú margaíochta dóibh, agus vacsaíní a bhfuil an próiseas liostaithe i ndáil le liosta úsáide éigeandála na hEagraíochta Domhanda Sláinte curtha i gcrích ina leith.
San Marino informed the Commission that it will accept proof of vaccination for vaccines with an EU wide authorization (following an opinion by the European Medicines Agency), vaccines that have been granted a temporary marketing authorisation by the competent authority of an EU Member State, and vaccines that have completed the WHO Emergency Use listing procedure.
Go háirithe, chuir Poblacht Shingeapór in iúl don Coimisiún go n-aithníonn sí gach vacsaín a bhfuil an próiseas maidir le Liostú Úsáide Éigeandála na hEagraíochta Domhanda Sláinte tugtha i gcrích ina leith, mar aon leis na vacsaíní atá údaraithe faoi Bhealach Rochtana Speisialta Paindéime Shingeapór.
In particular, the Republic of Singapore informed the Commission that it recognises all vaccines having finalised the World Health Organisation’s Emergency Use Listing procedure as well as those authorised under Singapore’s Pandemic Special Access Route.
Chun tacú le hobair EDS agus chun a ndícheall a dhéanamh idir-inoibritheacht dhomhanda níos fearr a bhaint amach, moltar do na Ballstáit go háirithe glacadh le deimhnithe vacsaínithe a eisítear do vacsaíní eile in aghaidh COVID-19 a bhfuil an nós imeachta maidir le liostáil úsáide éigeandála de chuid EDS curtha i gcrích ina leith.
In order to support the work of WHO and to strive for better global interoperability, Member States are in particular encouraged to accept vaccination certificates issued for other COVID-19 vaccines that have completed the WHO emergency use listing procedure.
Leis na nósanna imeachta comhchuibhithe faoi Rialachán (CE) Uimh. 726/2004, níor cheart cosc a chur ar na Ballstáit cinneadh a dhéanamh glacadh le deimhnithe vacsaínithe arna n-eisiúint le haghaidh vacsaíní eile in aghaidh COVID-19 ar dheonaigh údarás inniúil Ballstáit údarú margaíochta dóibh de bhun Threoir 2001/83/CE, vacsaíní ar tugadh údarú sealadach dá ndáileadh de bhun Airteagal 5(2) den Treoir sin, agus vacsaíní a bhfuil an nós imeachta maidir le liostáil úsáide éigeandála de chuid EDS curtha i gcrích ina leith.
Harmonised procedures under Regulation (EC) No 726/2004 should not prevent Member States from deciding to accept vaccination certificates issued for other COVID-19 vaccines that have been granted a marketing authorisation by the competent authority of a Member State pursuant to Directive 2001/83/EC, vaccines the distribution of which has been temporarily authorised pursuant to Article 5(2) of that Directive, and vaccines that have completed the WHO emergency use listing procedure.
Féadfaidh na Ballstáit glacadh, chun na críche céanna, le deimhnithe vacsaínithe arna n-eisiúint ag Ballstáit eile i gcomhréir leis an Rialachán seo le haghaidh vacsaín in aghaidh COVID-19 ar dheonaigh údarás inniúil Ballstáit údarú margaíochta di de bhun Threoir 2001/83/CE, le haghaidh vacsaín in aghaidh COVID-19 ar tugadh údarú sealadach dá dáileadh de bhun Airteagal 5(2) den Treoir sin, nó le haghaidh vacsaín in aghaidh COVID-19 a bhfuil an nós imeachta maidir le liostáil úsáide éigeandála de chuid EDS curtha i gcrích ina leith.
Member States may also accept, for the same purpose, vaccination certificates issued by other Member States in accordance with this Regulation for a COVID-19 vaccine that has been granted a marketing authorisation by the competent authority of a Member State pursuant to Directive 2001/83/EC, a COVID-19 vaccine the distribution of which has been temporarily authorised pursuant to Article 5(2) of that Directive, or a COVID-19 vaccine that has completed the WHO emergency use listing procedure.
Leis na nósanna imeachta comhchuibhithe faoi Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle, níor cheart cosc a chur ar na Ballstáit cinneadh a dhéanamh glacadh le deimhnithe vacsaínithe arna n-eisiúint le haghaidh vacsaíní eile in aghaidh COVID-19 ar dheonaigh údarás inniúil Ballstáit údarú margaíochta dóibh de bhun Threoir 2001/83/CE ó Pharlaimint na hEorpa agus ón gComhairle, le haghaidh vacsaíní ar tugadh údarú sealadach dá ndáileadh de bhun Airteagal 5(2) den Treoir sin, agus le haghaidh vacsaíní a bhfuil an nós imeachta maidir le liostáil úsáide éigeandála de chuid EDS curtha i gcrích ina leith.
Harmonised procedures under Regulation (EC) No 726/2004 of the European Parliament and of the Council should not prevent Member States from deciding to accept vaccination certificates issued for other COVID-19 vaccines that have been granted a marketing authorisation by the competent authority of a Member State pursuant to Directive 2001/83/EC of the European Parliament and of the Council, vaccines the distribution of which has been temporarily authorised pursuant to Article 5(2) of that Directive, and vaccines that have completed the WHO emergency use listing procedure.
Maidir leis na deimhnithe i ndáil le vacsaíniú, chuir Poblacht na Cóiré an Coimisiún ar an eolas nach nglacfar le deimhnithe ar a léirítear vacsaíní ag a bhfuil údarú uile-AE ach amháin má tá an nós imeachta maidir le liostáil úsáide éigeandála de chuid EDS curtha i gcrích ina leith.
Concerning the vaccination certificates, the Republic of Korea informed the Commission that certificates indicating vaccines with EU-wide authorisation will only be accepted if the vaccine has completed the WHO Emergency Use Listing procedure.
Chun feidhmiú na saorghluaiseachta a éascú do shaoránaigh den Aontas a fuair vacsaín in aghaidh COVID-19 a bhfuil an nós imeachta um liostú úsáide éigeandála de chuid EDS curtha i gcrích acu ina leith, moltar do na Ballstáit glacadh le Deimhnithe Digiteacha COVID AE a eisíodh tar éis na vacsaíní sin a thabhairt.
To facilitate the exercise of free movement of Union citizens who have received a COVID-19 vaccine that has completed the WHO emergency use listing procedure, Member States are also recommended to accept EU Digital COVID Certificates issued following the administration of such vaccines.
deimhniú vacsaínithe arna n-eisiúint i gcomhréir le Rialachán (AE) 2021/953 i ndáil le vacsaín in aghaidh COVID-19 a chumhdaítear leis an gcéad fhomhír d’Airteagal 5(5) den Rialachán sin nó i ndáil le vacsaín in aghaidh COVID-19 a bhfuil an nós imeachta um liostú úsáide éigeandála de chuid EDS curtha i gcrích aige agus a léiríonn go bhfuil an méid seo a leanas déanta ag an sealbhóir:
vaccination certificates issued in accordance with Regulation (EU) 2021/953 for a COVID-19 vaccine covered by Article 5(5), first subparagraph, of that Regulation or a COVID-19 vaccine that has completed the WHO emergency use listing procedure and which indicate that the holder has: